Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros

Base de dados
País como assunto
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Methods Mol Biol ; 2822: 143-156, 2024.
Artigo em Inglês | MEDLINE | ID: mdl-38907917

RESUMO

RNA in situ hybridization reveals the abundance and location of gene expression in cells or tissues, providing a technical basis for the clinical diagnosis of diseases. In this chapter, we show a "V" shape probe-mediated single-molecule chromogenic in situ hybridization (vsmCISH) technique for bright-field visualization of individual RNA molecules. In our method, several pairs of target hybridization probes are hybridized to RNA molecules and each probe pair forms a "V" shape overhang. The overhang oligonucleotides then mediated the proximity ligation to form DNA circles, followed by rolling circle amplification for signal enhancement and enzyme-catalyzed chromogenic reaction-based readout. The colorimetric assay avoids problems such as photobleaching and autofluorescence of current fluorescent in situ hybridization-based single-molecule RNA detection techniques. Furthermore, the relatively straightforward protocol makes the method useful for biological research and clinical diagnosis applications.


Assuntos
Hibridização In Situ , RNA , Hibridização In Situ/métodos , RNA/genética , RNA/análise , Humanos , Compostos Cromogênicos/química , Colorimetria/métodos , Imagem Individual de Molécula/métodos
2.
J Neurol ; 2024 May 08.
Artigo em Inglês | MEDLINE | ID: mdl-38717610

RESUMO

OBJECTIVE: To determine the efficacy and safety of perampanel (PER) as an adjunctive therapy in children aged 4-12 years with epilepsy. METHODS: We performed a non-randomized, open-label, placebo-uncontrolled, real-world self-controlled study that included 216 young children (aged 4-12 years) with epilepsy who received PER as adjunctive therapy at the children's hospital affiliated with Chongqing Medical University from July 4, 2020, to September 20, 2023. RESULTS: (1) The efficacy rates of adjunctive PER therapy at 3, 6, 9, and 12 months were 62.8%, 67.8%, 65.3%, and 61.2%, respectively. PER showed efficacy in alleviating focal seizures, generalized tonic-clonic seizures, myoclonic seizures, and absence seizures. The efficacy rates for variants of self-limited epilepsy with centrotemporal spikes (SeLECTS) and Lennox-Gastaut syndrome (LGS) were 89.5% and 66.7%, respectively. (2) Focal non-motor onset seizures with or without impaired awareness, focal to bilateral tonic-clonic seizures (FBTCS), LGS, variants of SeLECTS, the number of concomitant antiseizure medications (ASMs), a family history of epilepsy, and focal lesions on cranial magnetic resonance imaging were independent factors affecting efficacy. The order of PER addition did not affect efficacy. The retention rates at 3, 6, 9, and 12 months were 90.7%, 84.7%, 74.7%, 64.9%, respectively. (3) Adverse reactions occurred in 45 patients (45/216, 20.8%), with irritability/aggressive behavior (18/216, 8.3%) and somnolence (14/216, 6.5%) being the most common. Twelve patients (12/216, 5.6%) withdrew from the study because of adverse reactions. CONCLUSION: In young Chinese children with epilepsy, PER is effective, safe, and well-tolerated as an adjunctive therapy, making it a viable option for use with broad-spectrum ASMs.

3.
Microbiol Spectr ; 12(3): e0324423, 2024 Mar 05.
Artigo em Inglês | MEDLINE | ID: mdl-38275295

RESUMO

This study aims to summarize the clinical characteristics and prognosis of Listeria monocytogenes (LM) meningitis in children in Chongqing, China. A retrospective analysis of the clinical data and follow-up results of 20 LM meningitis patients admitted to the Children's Hospital of Chongqing Medical University (CHCMU) from January 2012 to December 2022 was performed. The LM meningitis incidence rate was between 0 and 14.3 per 100,000 persons. The median age at onset was 8.98 months. There were five neonate cases, which all had perinatal abnormalities. Seven non-neonatal cases (7/15, 46.7%) had a documented history of contaminated food intake. One case had primary immunodeficiency. The most common symptoms were fever (20/20), altered consciousness (19/20), and vomiting (15/20). Seven cases had seizures, eight cases had cranial nerve involvement, eight cases had positive Babinski sign, and 10 cases had positive meningeal signs. The most common complications were hyponatremia (6/20), hypokalemia (6/20), respiratory failure (5/20), subdural effusion (3/20), and hydrocephalus (2/20). Treatment primarily involved monotherapy or combination therapy with meropenem (15/20) and ampicillin (10/20). Fifteen cases were treated with monotherapy or combination therapy using vancomycin. Twelve cases were successfully followed up from 10 months to 9 years and 6 months, and all had favorable long-term outcomes. LM meningitis incidence in children is low and with nonspecific clinical manifestations. Strengthening food hygiene and safety education, and avoiding infections during pregnancy are important to prevent LM infection in neonates and high-risk individuals. Meropenem and ampicillin are the preferred treatments. Early diagnosis and treatment can improve prognosis.IMPORTANCEThe incidence of LM meningitis is extremely low, and there is currently no standardized treatment. We conducted a retrospective analysis of ten years of data from CHCMU regarding diagnosed LM meningitis cases, aiming to provide clinical evidence for the diagnosis and treatment.


Assuntos
Meningite por Listeria , Recém-Nascido , Gravidez , Feminino , Humanos , Criança , Lactente , Meningite por Listeria/diagnóstico , Meningite por Listeria/tratamento farmacológico , Meningite por Listeria/epidemiologia , Meropeném , Antibacterianos/uso terapêutico , Estudos Retrospectivos , Ampicilina/uso terapêutico , Prognóstico , China/epidemiologia , Hospitais
4.
Nanoscale ; 16(8): 4205-4211, 2024 Feb 22.
Artigo em Inglês | MEDLINE | ID: mdl-38324361

RESUMO

Using first-principles calculations, we report the realization of multiferroics in an intrinsic ferroelectric α-Ga2S3 monolayer. Our results show that the presence of intrinsic gallium vacancies, which is the origin of native p-type conductivity, can simultaneously introduce a ferromagnetic ground state and a spontaneous out-of-plane polarization. However, the high switching barrier and thermodynamic irreversibility of the ferroelectric reversal path disable the maintenance of ferroelectricity, suggesting that the defect-free form should be a prerequisite for Ga2S3 to be multiferroic. Through applying strain, the behavior of spontaneous polarization of the pristine α-Ga2S3 monolayer can be effectively regulated, but the non-magnetic ground state does not change. Strikingly, via an appropriate concentration of hole doping, stable ferromagnetism with a high Curie temperature and robust ferroelectricity can be concurrently introduced in the α-Ga2S3 monolayer. Our work provides a feasible method for designing 2D multiferroics with great potential in future device applications.

5.
J Phys Chem Lett ; 15(4): 1121-1129, 2024 Feb 01.
Artigo em Inglês | MEDLINE | ID: mdl-38263631

RESUMO

Using first-principles calculations combined with a constant-potential implicit solvent model, we comprehensively studied the activity of oxygen electrode reactions catalyzed by electride-supported FeN4-embedded graphene (FeN4Cx). The physical quantities in FeN4Cx/electrides, i.e., work function of electrides, interlayer spacing, stability of heterostructures, charge transferred to Fe, d-band center of Fe, and adsorption free energy of O, are highly intercorrelated, resulting in activity being fully expressed by the nature of the electrides themselves, thereby achieving a precise modulation in activity by selecting different electrides. Strikingly, the FeN4PDCx/Ca2N and FeN4PDCx/Y2C systems maintain a high oxygen evolution reaction (OER) and oxygen reduction reaction (ORR) activity with the overpotential less than 0.46 and 0.62 V in a wide pH range. This work provides an effective strategy for the rational design of efficient bifunctional catalysts as well as a model system with a simple activity-descriptor, helping to realize significant advances in energy devices.

6.
ChemSusChem ; 16(7): e202202209, 2023 Apr 06.
Artigo em Inglês | MEDLINE | ID: mdl-36571161

RESUMO

Developing high-performance electrocatalysts for the CO2 reduction reaction (CO2 RR) holds great potential to mitigate the depletion of fossil feedstocks and abate the emission of CO2 . In this contribution, using density functional theory calculations, we systematically investigated the CO2 RR performance catalyzed by TM2 -B2 (TM=Sc, Ti, V, Cr, Mn, Fe, Co, Ni, Cu) supported on a defective C3 N monolayer (V-C3 N). Through the screening in terms of stability of catalyst, activity towards CO2 adsorption, and selectivity against hydrogen evolution reaction, Mn2 -, Fe2 -, Co2 -, and Ni2 -B2 @V-C3 N were demonstrated to be a highly promising CO2 RR electrocatalyst. Due to quadruple active sites, these candidates can adsorb two or three CO2 molecules. Strikingly, different products, distributing from C1 to C2+ , can be generated. The high activity originates from the synergistic effect of TM and B atoms, in which they serve as adsorption sites for the C- and O-species, respectively. The high selectivity towards C2+ products at the Fe2 -, and Ni2 -B2 sites stems from moderate C adsorption strength but relatively weak O adsorption strength, in which a universal descriptor, that is, 0.6 ΔEC -0.4 ΔEO =-1.77 eV (ΔEC /ΔEO is the adsorption energy of C/O), was proposed. This work would offer a novel perspective for the design of high active electrocatalysts towards CO2 RR and for the synthesis of C2+ compounds.

SELEÇÃO DE REFERÊNCIAS
Detalhe da pesquisa